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Functional neuroimaging effects of recently discovered
genetic risk loci for schizophrenia and polygenic risk
proﬁle in ﬁve RDoC subdomains
S Erk1,2,12, S Mohnke1,2,12, S Ripke1,3, TA Lett1,2, IM Veer1,2, C Wackerhagen1,2, O Grimm4, N Romanczuk-Seiferth1, F Degenhardt5,6,
H Tost7, M Mattheisen8, TW Mühleisen9,10, K Charlet1, N Skarabis1,2, F Kiefer7, S Cichon9,10, SH Witt11, MM Nöthen5,6, M Rietschel11,
A Heinz1,13, A Meyer-Lindenberg7,13 and H Walter1,2,13
Recently, 125 loci with genome-wide support for association with schizophrenia were identiﬁed. We investigated the impact of
these variants and their accumulated genetic risk on brain activation in ﬁve neurocognitive domains of the Research Domain
Criteria (working memory, reward processing, episodic memory, social cognition and emotion processing). In 578 healthy subjects
we tested for association (i) of a polygenic risk proﬁle score (RPS) including all single-nucleotide polymorphisms (SNPs) reaching
genome-wide signiﬁcance in the recent genome-wide association studies (GWAS) meta-analysis and (ii) of all independent
genome-wide signiﬁcant loci separately that showed sufﬁcient distribution of all allelic groups in our sample (105 SNPs). The RPS
was nominally associated with perigenual anterior cingulate and posterior cingulate/precuneus activation during episodic memory
(PFWE(ROI) = 0.047) and social cognition (PFWE(ROI) = 0.025), respectively. Single SNP analyses revealed that rs9607782, located near
EP300, was signiﬁcantly associated with amygdala recruitment during emotion processing (PFWE(ROI) = 1.63 × 10
− 4, surpassing
Bonferroni correction for the number of SNPs). Importantly, this association was replicable in an independent sample (N= 150;
PFWE(ROI)o0.025). Other SNP effects previously associated with imaging phenotypes were nominally signiﬁcant, but did not
withstand correction for the number of SNPs tested. To assess whether there was true signal within our data, we repeated single
SNP analyses with 105 randomly chosen non-schizophrenia-associated variants, observing fewer signiﬁcant results and lower
association probabilities. Applying stringent methodological procedures, we found preliminary evidence for the notion that genetic
risk for schizophrenia conferred by rs9607782 may be mediated by amygdala function. We critically evaluate the potential caveats
of the methodological approaches employed and offer suggestions for future studies.
Translational Psychiatry (2017) 7, e997; doi:10.1038/tp.2016.272; published online 10 January 2017
INTRODUCTION
Schizophrenia, a severe and often chronic disease that affects
~ 1% of the population, has one of the highest heritability
estimates in psychiatry (80%).1 Genome-wide association studies
(GWAS) have been uncovering an increasing number of common
variants underlying disease susceptibility, promising valuable
insights into pathogenic biological pathways. The largest GWAS
to date including 36 989 cases and 113 075 controls identiﬁed 125
genetic loci (of which 108 were independent) associated with
schizophrenia.2
It was suggested that investigating important neurocognitive
domains implemented within speciﬁc brain circuits could be a
promising way for biological psychiatry. The Research Domain
Criteria (RDoC) approach3,4 postulates ﬁve major domains
(negative valence, positive valence, cognition, social processes
and arousal/regulation) containing several subdomains of which
many are relevant to schizophrenia. Following the RDoC rationale,
in order to uncover biological mechanisms underlying mental
illness, these domains warrant investigation at different units of
analyses, including genetics and brain circuits. In the last years,
imaging genetics studies investigated the impact of genetic risk
variants on domain-related brain circuits (for overviews see
refs 5–7). In our own previous work we were able to identify
potential intermediate phenotypes8,9 in ﬁve RDoC subdomains
(working memory (WM), episodic memory, reward processing (RP),
social cognition and emotion processing) that were modulated by
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risk variants within schizophrenia-associated variants (for example,
CACNA1C, ZNF804A).10–13 Importantly, several of these ﬁndings
were successfully replicated in independent samples.14–16
However, all of these studies as well as the overwhelming
majority of all other published imaging genetics investigations
(see Stein et al.17 for a notable exception, though using structural
neuroimaging) have been performed with single genetic variants
and usually with only one neurocognitive paradigm.
A crucial next step is to comprehensively investigate the impact
of the 108 independent schizophrenia-associated loci uncovered
recently.2 One approach complementing single single-nucleotide
polymorphism (SNP) analyses is the use of polygenic risk proﬁles.
As the accumulation of genetic variants is known to form a
substantial proportion of genetic susceptibility to psychiatric
disease,18 Purcell et al.19 proposed the use of a polygenic risk
proﬁle score (RPS), a sum across risk alleles of multiple SNPs
weighted by their effect size in an independent study. Employing
RPS is considered a feasible approach to investigate the combined
genetic impact of multiple variants in small samples.20 However,
investigating the linear combination of several hundreds or
thousands of variants may come at the expense of losing
speciﬁcity; that is, RPS may obscure information conveyed by
single or subsets of genes. Therefore, we decided to employ two
complementary exploratory analyses. We investigated a range of
promising intermediate phenotypes evoking activation of dedi-
cated brain circuits relevant for schizophrenia (WM, episodic
memory, RP, social cognition and emotion processing). These ﬁve
neurocognitive subdomains cover four of the ﬁve general RDoC
domains, that is, negative valence, positive valence, cognition and
social cognition. First, we tested for association with an RPS
including all SNPs reaching genome-wide signiﬁcance (Po5×10−8;
combined risk of 125 SNPs) in the recent GWAS meta-analysis.
Second, we tested the effects of all genome-wide signiﬁcant single
variants that showed sufﬁcient distribution of all allelic groups within
our sample in order to identify contributions of speciﬁc variants.
Results were assessed within task-speciﬁc target areas located within
widespread brain circuits (Supplementary Figure S2).
MATERIALS AND METHODS
Subjects
A total of 578 German volunteers who never suffered from psychiatric
disorder (evidenced by SCID-I)21 were recruited at Mannheim, Berlin and
Bonn as part of an ongoing study on neurogenetic mechanisms of unipolar
depression, bipolar disorder and schizophrenia (http://www.ngfn.de/en/
schizophrenie.html; http://www.sys-med.de/en/consortia/integrament/).
N=333 participants had no lifetime family history of schizophrenia or an
affective disorder, and n= 245 subjects had at least one ﬁrst-degree
relative affected by schizophrenia (n=72), bipolar disorder (n= 71) or
depression (n=102). Affected index patients did not suffer from any other
psychotic or affective disorder, and the investigated relatives had no family
history of multiple different psychiatric diagnoses (for example, cases of
both, affective and psychotic disorders). All subjects had grandparents of
European origin. Following application of exclusion criteria n= 472–509
subjects were included in the analyses of the respective tasks (see
Supplementary Material for details). N=150 controls recruited as part of a
study on the neurogenetic mechanisms of alcohol dependence in Berlin
and Bonn (http://www.ngfn.de/en/alkoholabh__ngigkeit.html)22 served as
replication sample. All participants never suffered from psychiatric disorder
according to the Structured Clinical Interview of the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) Axis-I Disorders (SCID-I).21
Demographic characteristics of the respective subsamples are given in
Supplementary Tables S1 and S2. The study was approved by local ethics
committees of the universities of Heidelberg, Berlin and Bonn. All
participants gave written informed consent to the study according to
the Declaration of Helsinki.
DNA extraction and genotyping
Ethylenediaminetetraacetic acid anticoagulated venous blood samples
were collected from all individuals. Lymphocyte DNA was isolated using
the Chemagic Magnetic Separation Module I (Chemagen, Baesweiler,
Germany) according to the manufacturer’s recommendations. A genome-
wide data set was generated at the Department of Genomics, Life & Brain
Center, University of Bonn using Illumina’s Human610Quad, Human660W-
Quad and Inﬁnium PsychArray-24 BeadChips (Illumina, San Diego, CA,
USA). Quality control and imputation were performed with standard
parameters used by the Psychiatric Genetics Consortium (PGC) Statistical
Analyses Group and RPS were calculated using methods described by
Purcell et al.19 (see Supplementary Material for details).
Functional imaging tasks
During functional magnetic resonance imaging (fMRI) subjects completed
an associative episodic memory (EM) task requiring encoding, recall and
recognition of face-profession pairs. The WM n-back task required
continuous updating and retrieval of elements held in short-time memory.
The RP monetary incentive delay task allowed the study of anticipation of
monetary gains or losses. The Theory of Mind (ToM) task consisted of
cartoon stories requiring subjects to take the protagonist’s perspective and
judge changes in his/her affective states. The face-matching task (FMT)
operationalized subjects’ implicit processing of negative emotions while
viewing faces showing either fearful or angry expressions (for detailed
descriptions see refs 10–13 and Supplementary Material). All tasks were
previously shown to robustly activate target structures and to possess
excellent test–retest reliability in between-group designs.12,16,23,24
Imaging parameters
Blood-oxygen-level dependent fMRI was performed on three Siemens Trio
3 T MR-Tomographs at the Life and Brain Center of the University of Bonn,
the Central Institute of Mental Health Mannheim, and the Charité-
Universitätsmedizin Berlin. At all sites, identical sequences and scanner
protocols were employed (EM: 33 slices, axially tilted (−30°), slice thickness
2.4 mm+0.6 mm gap, ﬁeld of view (FOV) 192 mm, repetition time (TR)
1.96 s, echo time (TE) 30 ms, ﬂip angle 80°, all other fMRI tasks: 28 slices,
slice thickness 4 mm+1 mm gap, FOV 192 mm, TR 2 s, TE 30 ms, ﬂip angle
80°). Quality-control measurements were conducted at all sites on every
day of data collection according to a multicenter quality-assurance
protocol, revealing stable parameters over time.25 To account for any
variance related to differences across sites, the site was used as a covariate
for all statistical analyses.
Functional image processing
Image processing and statistical analyses were conducted using statistical
parametric mapping methods as implemented in SPM8 (http://www.ﬁl.ion.
ucl.ac.uk/spm/software/spm8/). Scans were subjected to a strict quality
assessment before inclusion into further analyses. Following data-quality
assessment and application of general exclusion criteria (see above)
n= 472–509 subjects were included in the respective analyses (see
Supplementary Figure 1 and Supplementary Methods for details). During
pre-processing, images were realigned to a mean image (movement
parameters conﬁned to o3 mm translation and o1.7° rotation between
volumes), slice-time-corrected, spatially normalized to a standard stereo-
tactic space (a brain template created by the Montreal Neurological
Institute) with a voxel size of 3 × 3× 3 mm and smoothed with a 9 mm full
width at half maximum Gaussian ﬁlter. A ﬁrst-level ﬁxed-effects model was
computed for each participant and task. Regressors were created from the
time course of the experimental conditions of interest per task and
convolved with a canonical hemodynamic response function. Movement
parameters, and for the ToM task also instructions and button presses,
were included in the ﬁrst-level models as covariates of no interest. For each
subject, individual contrast images of the task effect (WM: 2-back40-back;
EM: memory4control; RP: anticipation of monetary win/loss4anticipation
of neutral outcomes; ToM: mentalizing4control; FMT: faces4shapes) were
subsequently entered into group statistics.
Statistical group analyses
RPS: To test for genetic association with the intermediate phenotypes, the
respective individual contrast images were analyzed using second-level
multiple regression models for each task, including the RPS as regressor of
interest, and age, sex, site, subgroup (no familial liability for psychiatric
disorders, affected ﬁrst-degree relative of patients with schizophrenia, bipolar
disorder or depression), chip used for genotyping and the ﬁrst three principal
components (derived from a statistically independent set of common SNPs
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representing potential population stratiﬁcation) as nuisance covariates.
Effects of RPS on predeﬁned regions of interest (ROIs) were assessed
determining the familywise error (FWE)-corrected signiﬁcance values of the
maximally activated voxel within each ROI using undirected tests.
For the WM, EM and FMT tasks, ROIs were deﬁned a priori using
anatomical labels provided by the Wake Forest University Pick Atlas (www.
fmri.wfubmc.edu/downloads). These were the bilateral dorsolateral prefrontal
cortex (BA46 and BA9 with subtraction of medial voxels of BA9, see Esslinger
et al.11 for details) for the WM task, the left and right hippocampus and
perigenual anterior cingulate cortex (pgACC) for EM tasks and the bilateral
amygdala, as well as the pgACC for the FMT (Supplementary Figure S2). As
the AAL atlas does not provide anatomical labels for the ventral striatum, a
spherical ROI was created for the RP task using a voxel located in the center
of the ventral striatum (x=±9, y=11, z=−8) surrounded by a sphere of
10 mm. For the ToM task, four functional ROIs were created for those regions
previously shown to be aberrantly activated in patients with schizophrenia
(for example, Sugranyes et al.26; Walter et al.27) and to be genetically
modulated.13,16 As these regions were not covered by speciﬁc AAL ROIs,
masks for the medial prefrontal cortex, bilateral temporal parietal junction
(TPJ) and posterior cingulate cortex/precuneus (PCC/Pcu) were created based
on coordinates reported by a meta-analysis on brain areas involved in ToM28
using the toolbox TWURoi (see Supplementary Material for details).
Single SNP fMRI analyses
Comparable to RPS analyses, second-level multiple regression models were
computed for each SNP and each task with number of minor alleles as
regressor of interest, and age, sex, site, subgroup, genotyping chip and the
ﬁrst three principal components of potential population stratiﬁcation as
nuisance covariates. We excluded SNPs with less than 10 subjects in one
allelic group, resulting in 105 independent analyses. Similar to RPS
analyses, we extracted FWE-corrected P-values of the maximally activated
voxel within each ROI for each SNP from an undirected test. These
signiﬁcance values were then Bonferroni-corrected for the number of
autosomal SNPs tested, that is, 105 (Po4.76 × 10− 4).
We used an undirected F-test in all analyses, as, for the investigated RPS
and the vast majority of SNPs, we had no hypotheses about the directionality
of effects. Associations with the intermediate phenotype could be
represented by reduced or increased activation, being either indicative of
dysfunction, inefﬁciency or compensatory resilience mechanisms.
RESULTS
Polygenic RPSs
There were two signiﬁcant associations between RPS and
functional brain activation: accumulated genetic risk-predicted
pgACC recruitment during EM recognition (x=− 3, y= 26, z=− 11,
F = 13.72, Z= 3.49, PFWE(ROI) = 0.047) and PCC/Pcu activity during
ToM (x=− 9, y=− 55, z= 22, F = 13.90, Z= 3.52, PFWE(ROI) = 0.025;
Figure 1, Supplementary Figure S4).
Genome-wide signiﬁcant SNPs
A median number of 4 (range 0–8) SNPs surpassed standard
correction for multiple comparisons (PFWE(ROI)o0.05) across ROIs
(Figure 2, Table 1, Supplementary Table S3). These included
replicated risk variants for schizophrenia associated with imaging
phenotypes before, for example, rs11696094 (ZNF804A; ToM, RP),
rs2007044 (CACNA1C; EM, RP), rs1702294 (miR137; EM) and
rs9636107 (TCF4; EM). However, only one single SNP association
withstood correction for multiple comparisons (number of tests
per ROI), that is, rs9607782 (chr22, 41.40–41.68 Mb, hg19.37;
located in an linkage disequilibrium (LD) block with EP300,
L3MBTL2, CHADL and RANGAP) predicted right amygdala activa-
tion during the FMT (x= 27, y= 5, z=− 17, F = 21.45, Z= 4.43,
PFWE(ROI) = 1.63 × 10
− 4; Figure 3).
Replication analysis
We could replicate the effect of rs9607782 on amygdala activation
in an independent control sample using the identical FMT (x= 30,
y=− 4, z=− 11, F = 10.94, Z= 3.04, PFWE(ROI) = 0.025; Figure 3). In
both samples amygdala activity decreased with increasing
number of risk alleles for schizophrenia.
Analyses of LD-independent non-schizophrenia-associated SNPs
(n= 105)
In order to assess the adequacy of correcting for the number of
SNPs tested per ROI, we determined the number of signiﬁcant
effects of 105 common variants not signiﬁcantly associated with
schizophrenia on all neuroimaging phenotypes. Therefore, we
generated a random set of 10 000 SNPs across the whole genome.
From this set we randomly selected 105 variants with a P-value
of 40.2 for association with schizophrenia and a minor allele
frequency of 410%/o90% in the PGC_SCZ52 data set. We
observed a median of three (range 0–7) signiﬁcant hits applying a
threshold of PFWE(ROI)o0.05 across the respective ROIs. None of
these associations withstood correction for the number of variants
tested per ROI (Supplementary Figure S3). The difference between
the number of statistically meaningful associations per ROI using
schizophrenia-related and -unrelated SNPs was marginally
Figure 1. Results for the polygenic risk score (including all SNPs associated with schizophrenia at a genome-wide level, n= 125) for regions of
interest. Dashed line indicates –log10 P-value of familywise error correction for regions of interest in all tasks (PFWE(ROI)= 0.05). x axis: region of
interest, y axis: − log10 P-value for F-tests. AMY, amygdala; DLPFC, dorsolateral prefrontal cortex; EM, episodic memory; FMT, face-matching
task; HC, hippocampus; l, left; pgACC, perigenual anterior cingulate cortex; MPFC, medial prefrontal cortex; Pcu/PCC, precuneus/posterior
cingulate cortex; r, right; RP, reward processing; SNP, single-nucleotide polymorphism; ToM, Theory of Mind; TPJ, temporoparietal junction;
VSTR ventral striatum; WM, working memory.
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Figure 2. Results of analyses of single SNPs reaching genome-wide signiﬁcance for association with schizophrenia for regions of interest in all
tasks. Dashed line indicates –log10 P-value of familywise error correction for respective region of interest. Red line indicates –log10 P-value of
correction for multiple tests (P= 4× 10− 4). x axis: number of SNP, ordered by position within chromosome, y axis: − log10 P-value of F-tests.
EM, episodic memory; FMT, face-matching task; RP, reward processing; ToM, Theory of Mind; SNP, single-nucleotide polymorphism; WM,
working memory.
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signiﬁcant (P= 0.06 after 10 000 permutations; one-tailed t-test).
However, overall the P-values observed with schizophrenia-
associated variants were signiﬁcantly lower than among associa-
tions with unrelated variants (Po0.005 after 10 000 permutations;
one-tailed t-test; see Supplementary Material for details).
DISCUSSION
We investigated the impact of genetic risk for schizophrenia on a
range of functional imaging phenotypes reliably activating
distributed brain networks covering ﬁve RDoC subdomains with
well-established relevance to the disease. We analyzed the effects
of (i) a polygenic RPS and (ii) of 105 single SNPs genome-wide
signiﬁcantly associated with schizophrenia in face of beneﬁts and
drawbacks of both approaches. RPS offer assessment of accumu-
lated genetic risk in a limited number of tests, but prohibit
conclusions regarding speciﬁc contributions of SNPs and might
conceal effects of some risk variants when combined with
irrelevant signals. Single SNP analyses on the other hand have
the disadvantage that the higher amount of tests (i) heightens the
risk of false-positive results if not correctly accounted for (type I
error) and (ii) increases the likelihood to ﬁnd only those effects
whose effect size is overestimated (winner’s curse).
The analysis of the polygenic RPS revealed two signiﬁcant
associations at a standard neuroimaging signiﬁcance level
(PFWE(ROI)o0.05). The RPS predicted pgACC activity during EM
recognition. pgACC recruitment was previously found to be
modulated by genetic risk for schizophrenia during active EM
retrieval. Furthermore, we found an association between RPS and
PCC/Pcu activity during ToM. Activation of the PCC/Pcu, one of the
crucial mentalizing areas, has been associated twice with a risk
variant within ZNF804A (rs1344706) in high LD with a SNP
included in the RPS (rs11693094; R2 = 0.84). However, it must be
emphasized that these results would not withstand multiple
comparison correction for the total number of ROI analyses across
all tasks (Po0.0025, that is, Po0.05 FWE across 20 ROI analyses).
With such a stringent threshold none of the above-mentioned
results would remain signiﬁcant and, in fact, one false-positive
ﬁnding would be expected in 20 independent tests (at P= 0.05).
As we investigated 105 independent SNPs, we strictly corrected
for this number within each ROI. Only one association withstood
correction for multiple testing: rs9607782 was associated with
right amygdala activity during implicit emotion processing. To the
best of our knowledge, this SNP was not previously investigated in
imaging genetics studies. Rs9607782 is located in an LD block with
EP300, L3MBTL2, CHADL and RANGAP, and is in high LD (R2 = 0.77)
with a missense mutation in EP300 (rs20551), suggesting functional
relevance. Besides association with schizophrenia, mutations in the
EP300 gene are responsible for the Rubinstein-Taybi syndrome, a
developmental disorder that includes intellectual disability, impul-
sivity, distractibility and mood instability.29 EP300 encodes p300, a
protein that functions as histone-acetyltransferase and is expressed
in the brain in limbic and cortical regions. In mice, inhibition of p300
activity signiﬁcantly impairs fear memory consolidation, and
associated neural plasticity in the lateral amygdala.30 P300
inhibition further induced enhanced anxiety and mild cognitive
impairment in a water maze task.31 Altered emotional signiﬁcance
detection and maladaptive appraisal have been associated with
amygdala dysfunction in schizophrenia before.32–34 Thus, previous
evidence supports the potential relevance of the observed
association, particularly as we were able to replicate our result in
an independent sample (Figure 3). This ﬁnding taps into the RDoC
domains social cognition and negative valence. Importantly, the
fMRI paradigm used to measure this potential intermediate
phenotype is well qualiﬁed as an RDoC subdomain as it fulﬁlls
required criteria for good psychometric properties,24 association
with psychopathology (association with schizophrenia was repeat-
edly shown on the behavioral and the brain level)35,36 and
heritability (with heritability estimates for emotion identiﬁcation
ranging between 0.21 and 0.43).37,38
Other associations, although not surviving correction for
multiple comparisons, include SNPs previously found to be related
to imaging phenotypes from all RDoC domains assessed (see
Table 1), for example, rs2007044 within CACNA1C was associated
with hippocampal activity during EM,10,14,15,39 but also with
bilateral ventral striatal activation during RP. Rs11693094 within
ZNF804A was associated with activity of ToM areas (medial
prefrontal cortex, left temporal parietal junction) as shown
before13,16 and also with striatal activity. In addition, there were
associations of variants within TCF4 (previously found to have an
impact on hippocampal volume)40 with hippocampal and pgACC
activity during EM as well as with amygdala recruitment during
implicit emotion processing. rs1702294 within MIR137 (gene
previously found to have an impact on frontalmediotemporal
connectivity)41,42 was associated with hippocampal activity, and
rs2905426 within NCAN (previously associated with cortical
thickness and folding in schizophrenia)43,44 was associated with
ventral striatal activation during RP.
All of these effects would stand out as signiﬁcant hits in
association studies on imaging phenotypes that typically apply a
threshold of PFWE(ROI)o0.05. However, an increasing number of
statistical tests always comes at the expense of an increasing risk
of type I error if not corrected for properly. In total, we found a
median of 4 and up to 8 signiﬁcant hits per ROI, which again,
given a signiﬁcance threshold of Po0.05, is compatible to chance
ﬁndings in 105 tests. In fact, these numbers correspond well with
those found by Sullivan who observed similar numbers in
simulated genetic data containing no valid associations.45 In his
data, an uncorrected signiﬁcance level of Po0.05 yielded a
proportion of false-positive ﬁndings of 96.8% (at least one positive
ﬁnding in 968 of 1000 simulations). When Sullivan corrected for
the number of SNPs he tested (which is in accordance to what we
did) he still found a false-positive proportion of 31.4%.45 Thus,
accounting for the number of SNPs may still be insufﬁcient and
additional correction for the number of ROIs could be necessary.
Indeed, Sullivan reported that correction for the total number of
independent tests resulted in the appropriate false-positive
Figure 3. Effects of rs9607782 on right amygdala activity during
implicit emotion processing. Results are Po0.05 FWE-corrected
across the ROI. The effect in the discovery sample additionally
withstood Bonferroni correction for the number of SNPs tested
(n= 105), that is, PFWEo0.0004. N, sample size; FWE, familywise error;
ROI, region of interest; SNP, single-nucleotide polymorphism.
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proportion of 5%. Application of such strict correction for our
single SNP analyses (in our case Po2.3 × 10− 5) would result in no
ﬁnding being interpretable as statistically signiﬁcant. On the other
hand, the combination of FWE correction across ROIs with
Bonferroni correction for the number of tests could be too
conservative for fMRI data, taking into account that task-related
ROI activation may be highly correlated, that is, is not truly
independent. By testing associations of 720 SNPs not associated
with schizophrenia with functional brain correlates of WM and
implicit emotion processing Meyer-Lindenberg et al.46 showed that
the false-positive proportion was no higher than 1.0–4.1% applying
FWE correction alone. If this applies to our data, those SNPs
surpassing the standard threshold of PFWE(ROI)o0.05 may be true
ﬁndings. Hence, to evaluate whether our ﬁndings contain true
signal, we applied a similar strategy by testing the association of 105
SNPs not associated with schizophrenia or any mental function with
our imaging phenotypes. Whereas the statistical difference for the
total number of statistical meaningful associations among
schizophrenia-related and -unrelated variants fell short of the
signiﬁcance threshold, we observed signiﬁcantly higher probabil-
ities for associations of disease-related than -unrelated variants.
These results at least tentatively suggest further true signal in our
data. Nevertheless, we believe that in face of the large amount of
analyses we carried out in total, independent replication is essential
and should be made mandatory in imaging genetics research, just
as in psychiatric genetics research.
Our ﬁndings point to several issues relevant to the ﬁeld of
imaging genetics. It is foreseeable that larger genetic studies will
discover more genome-wide signiﬁcant genetic variants associated
with psychiatric disorders. A brute force approach, that is, testing
and correcting for all signiﬁcantly associated variants known, will
require a magnitude of statistical power difﬁcult to achieve in
functional imaging. There are three principal ways to respond to
this conundrum. First, increase sample sizes (the mantra of
genetics), for example, through consortial data accumulation
worldwide. This is a reasonable path that has already been taken
by the ENIGMA consortium47 to which we have contributed
too.17,48 However, costs and data availability limit this path and, in
the foreseeable future, (relatively) large sample sizes will likely be
restricted to structural and resting state data. The aggregation of
task-related functional data will be even more difﬁcult because of
demands on harmonization of experimental procedures and
psychometric task properties. Second, restrict analyses to theory-
driven a priori hypotheses. This is formally correct but the possibility
remains that ‘suitable’ hypotheses are established post hoc after
extensive data mining. Hence, this is difﬁcult to control without
prior registration of hypotheses, in particular as more and more
groups are performing genome-wide genotyping. That said,
exploratory analyses should still be accepted if labeled appro-
priately and substantiated by replication studies. Third, and most
forward-looking, the use of data reduction, feature selection and
multivariate methods.49 Data reduction methods might include
polygenic RPSs, gene set enrichment analyses or pathway analyses
on the genetic side, and network analyses, independent compo-
nent analyses, or graph theory on the imaging side. In addition,
multivariate machine-learning methods might be useful to map
high-dimensional genetic and neuroimaging data sets—this,
however, also requires relatively large data sets.
Apart from these three principal approaches we would like to
encourage the ﬁeld to publish replication studies and in particular
negative ﬁndings to enable future meta-analytical approaches. In
addition, standards should be developed calling on imaging
genetic studies to additionally publish whole-brain-effect sizes to
facilitate replication and meta-analysis.
Our results suggest that risk scores aggregated across multiple
independent loci may be less helpful than hoped for intermediate
phenotype characterization. There is some evidence that brain
effects are not as linear as associations with a (linear) polygenic RPS
would imply.50 Further, it should be emphasized that comparable
polygenic scores do not necessarily include the same combination
of risk variants. Each individual will rather have a unique
combination of risk variants, and it is thus not reasonable to
assume that similar scores will have an impact on the same neural
region or circuit. A possible solution would be genotyping a large
sample of individuals and deeply phenotyping (using, for example,
neuroimaging) a subset at the upper and lower tail of the
distribution. This does not speak against the usefulness of RPS in
general, but in intermediate phenotype research, more hypothesis-
driven approaches to RPS deﬁnition may prove more fruitful.
Coming back to our own study presented here, we remind that
our data are limited by the combined analyses of subjects with
and without familial liability for psychiatric disorders. Still, all
subjects had a negative lifetime history of psychiatric disorders as
evidenced by a respective diagnostic interview and we accounted
for subgroup status in all of our analyses.
Please note also that, in order to limit our variables on the
imaging side, we restricted our analyses to regional effects using a
ROI approach and did not test for other possible measures that
focus on connectivity11 or network parameters.51,52
In summary, although it unquestionably is a big challenge to
acquire enough functional neuroimaging data for strict correction
of both high-dimensional data sets (that is, imaging and genetics)
using a brute force approach, we plead for the continuation of
acquiring, analyzing and publishing imaging genetics results.
These should include theory-driven restricted analyses, as well as
stringent signiﬁcance level adjustment and independent replica-
tion. Implementing these methodological requirements, our most
robust ﬁnding was an association between a variant near EP300
with amygdala function during implicit emotion processing, a
ﬁnding that is supported by preclinical and clinical ﬁndings and
points to a disease-relevant mechanism potentially mediating
aberrant anxiety processing and/or fear memory.
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